SDI Reports: Top 20% Of Endocrinologists Write 95% Of New-To-Brand Oral Diabetes Prescriptions - Percentages Differ For GPs

According to SDI, the leader in innovative analytics for the pharmaceutical and healthcare industries, 20% of endocrinologists who wrote prescriptions for oral diabetes therapies from September 2007 through August 2008 were responsible for 95% of new-to-brand prescriptions in that specialty; that is, new product starts, add-on therapy, or product switches.

More: continued here

Filed under: Diabetes on October 3rd, 2008